MedPath

Growth and Plasma Amino Acids in Infants With CMPA and Treated With a Newly Innovated Amino Acid Formula

Active, not recruiting
Conditions
Cow Milk Allergy
Registration Number
NCT01637688
Lead Sponsor
Mahidol University
Brief Summary

The purpose of this study is to determine growth and protein status of infants with cow's milk protein allergy and treated with a newly innovated amino acid formula compared to those with a commercial amino acid formula.

Detailed Description

Severe cases of cow's milk protein allergy are treated with the amino acid formula. The amino acid formula is composed of essential and non-essential amino acids, vegetable oils with or without MCT oil, and glucose polymer from various carbohydrate sources. Such formula is also fortified by minerals, trace elements,and vitamins.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
81
Inclusion Criteria
  • Singleton
  • Clinical diagnosis of cow's milk protein allergy
Exclusion Criteria
  • Other diseases

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Growth and protein status4 weeks

* compare body weight, length, head circumference, triceps skin fold thickness, mid-arm circumference, and arm muscle area between NAAF and AAF groups

* compare plasma amino acids, serum albumin, blood urea nitrogen, and creatinine between NAAF and AAF groups

Secondary Outcome Measures
NameTimeMethod
Growth4 weeks

* compare weight, length, head circumference, triceps skin fold thickness, mid-arm circumference, and arm muscle area between either NAAF group or AAF group and normal infants fed with either breast milk or infant formula.

* compare plasma amino acids between either NAAF group or AAF group and normal published data

Trial Locations

Locations (1)

Faculty of Medicine Siriraj Hospital

🇹🇭

Bangkok, Thailand

Faculty of Medicine Siriraj Hospital
🇹🇭Bangkok, Thailand

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.